000			01608 a2200433 4500
005			20250515100430.0
264		0	_c20080915
008			200809s 0 0 eng d
022			_a1755-3768
024	7		_a10.1111/j.1600-0420.2007.01106.x _2doi
040			_aNLM _beng _cNLM
100	1		_adell'Omo, Roberto
245	0	0	_aIntravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity. _h[electronic resource]
260			_bActa ophthalmologica _cSep 2008
300			_a698-700 p. _bdigital
500			_aPublication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aBevacizumab
650	0	4	_aFemale
650	0	4	_aGlaucoma, Neovascular _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInfant, Newborn
650	0	4	_aInjections
650	0	4	_aIntraocular Pressure
650	0	4	_aIris _xblood supply
650	0	4	_aNeovascularization, Pathologic _xdrug therapy
650	0	4	_aRetinal Detachment _xetiology
650	0	4	_aRetinopathy of Prematurity _xcomplications
650	0	4	_aVascular Endothelial Growth Factor A _xantagonists & inhibitors
650	0	4	_aVisual Acuity
650	0	4	_aVitreous Body
700	1		_aKulkarni, Avinash
700	1		_aFranks, Wendy A
773	0		_tActa ophthalmologica _gvol. 86 _gno. 6 _gp. 698-700
856	4	0	_uhttps://doi.org/10.1111/j.1600-0420.2007.01106.x _zAvailable from publisher's website
999			_c17594999 _d17594999